Affinity Asset Advisors’s Zura Bio ZURA Stock Holding History

Affinity Asset Advisors’s Portfolio ZURA Stock Details ZURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.64M	Sell	1,464,303 -1,100,000	-43%	-$5.24M	0.39%	65
2026 Q1	$15.3M	Buy	2,564,303 +750,632	+41%	+$4.53M	0.79%	35
2025 Q4	$9.5M	Buy	1,813,671 +539,320	+42%	+$2.13M	0.54%	47
2025 Q3	$5.52M	Buy	1,274,351 +1,051,016	+471%	+$1.89M	0.48%	48
2025 Q2	$235K	Hold	223,335	–	–	0.03%	83
2025 Q1	$288K	Hold	223,335	–	–	0.03%	89
2024 Q4	$558K	Hold	223,335	–	–	0.07%	75
2024 Q3	$907K	Hold	223,335	–	–	0.12%	74
2024 Q2	$782K	Sell	223,335 -226,674	-50%	-$924K	0.09%	84
2024 Q1	$1.16M	Buy	+450,009	New	+$1.59M	0.14%	81

Other funds holding ZURA

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Affinity Asset Advisors's ZURA Position: Q2 2026 in Review

Affinity Asset Advisors reduced its Zura Bio (ZURA) stake by 43% in Q2 2026, selling an estimated $5.24M and leaving 1,464,303 shares worth $8.64M. The position accounts for 0.39% of the portfolio, ranked #65.

Affinity Asset Advisors first reported a position in ZURA in Q1 2024 and has held it in 10 quarters since. The position peaked at $15.3M in Q1 2026. 95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

Affinity Asset Advisors held 1,464,303 shares of Zura Bio worth $8.64M as of Q2 2026.
Affinity Asset Advisors sold 1,100,000 Zura Bio shares in Q2 2026, an estimated $5.24M.
Zura Bio made up 0.39% of Affinity Asset Advisors's portfolio in Q2 2026, its #65 holding.
Affinity Asset Advisors first reported a position in Zura Bio in Q1 2024 and has held it in 10 quarters since.
Affinity Asset Advisors's Zura Bio position peaked at $15.3M in Q1 2026.
95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on Affinity Asset Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.